Background and Purpose: There are few data on the occurrence of microembolic signals (MES) in the acute phase of ischaemic stroke. The objective of our work was to systematically study the frequency of MES in non-selected patients with a first-ever hemispheric transient ischemic attack (TIA) or acute cerebral infarction, and to evaluate the clinical usefulness of MES detection. Methods: 182 consecutive patients with hemispheric TIA or acute cerebral infarction, and 54-age-matched healthy controls were studied. Bilateral transcranial Doppler ultrasound (TCD) monitoring was performed for at least 30 min with a mean time from stroke onset to TCD of 69 h. Stroke severity on admission, early recurrent stroke and dependency on discharge were investigated. Results: MES were detected in 20.5% of patients with arterial sources of embolism, 17.1% of patients with potential sources of cardioembolism and 5% of patients with cryptogenic stroke. They were not registered, however, in lacunar infarctions (p < 0.001). Stroke severity on admission of patients with MES was greater than that of patients without MES (47.1 vs. 19.4% with the Canadian Stroke Scale ≤6.5; p = 0.009). Early recurrent stroke was more frequent in patients with MES (11.8%) than in those without MES (4.2%) although the difference was not statistically significant. Multiple logistic regression analysis showed that MES increased the risk of dependency on discharge (odds ratio, 4.2; 95% CI, 1.2–14.9; p = 0.01) independently of age, stroke severity on admission and presence of an arterial or cardiac embolic source. Conclusions: There is a strong association of MES in the acute phase of stroke with known potential arterial and cardiac embolic sources. MES have an independent predictive value of poor outcome.

1.
Grosset DG, Georgiadis D, Abdullah I, Bone I, Lees KR: Doppler emboli signals vary according to stroke subtype. Stroke 1994;25:382–384.
2.
Tong DC, Albers GW: Transcranial Doppler-detected microemboli in patients with acute stroke. Stroke 1995;26:1588–9294.
3.
Sliwka U, Lingnau A, Stohlmann WD, Schmidt P, Mull M, Diehl RR, Noth J: Prevalence and time course of microembolic signals in patients with acute stroke. A prospective study. Stroke 1997;28:358–363.
4.
Del Sette M, Angeli S, Stara I, Finocchi C, Gandolfo C: Microembolic signals with serial transcranial Doppler monitoring in acute focal ischemic deficit. A local phenomenon? Stroke 1997;28:1311–1313.
5.
Koennecke HC, Mast H, Trocio SH Jr, Sacco RL, Ma W, Mohr JP, Thompson JL: Frequency and determinants of microembolic signals on transcranial Doppler in unselected patients with acute carotid territory ischemia. A prospective study. Cerebrovasc Dis 1998;8:107–112.
6.
Serena J, Segura T, Perez-Ayuso MJ, Bassaganyas J, Molins A, Dávalos A: The need to quantify right-to-left shunt in acute ischemic stroke. A case-control study. Stroke 1998;29:1322–1328.
7.
Consensus Committee of the Ninth International Symposium on Cerebral Hemodynamics: Basic identification criteria of microembolic signals. Stroke 1995;26:1123.
8.
Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, Chauvel C, Touboul PJ, Bousser MG: Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994;331:1474–1479.
9.
Daffertshofer M, Ries S, Schminke U, Hennerici M: High-intensity transient signals in patients with cerebral ischemia. Stroke 1996;27:1844–1849.
10.
Lindgren AL, Roijer A, Norrving B, Wallin L, Eskilsson J, Johansson BB: Carotid artery and heart disease in subtypes of cerebral infarction. Stroke 1994;25:2356–2362.
11.
Tong DC, Bolger A, Albers GW: Incidence of transcranial Doppler-detected cerebral microemboli in patients referred for echocardiography. Stroke 1994;25:2138–2141.
12.
Georgiadis D, Grosset D, Kelman A, Fairchney A, Lees K: Prevalence and characteristics of intracranial microemboli signals in patients with different types of prosthetic cardiac valves. Stroke 1994;25:587–592.
13.
Grosset DG, Cowburn P, Georgiadis D, Dargie HJ, Faichney A, Lee KR: Ultrasound detection of cerebral emboli in patients with prosthetic heart valves. J Heart Valve Dis 1994;3:128–132.
14.
Droste DW, Hagedorn G, Nötzold A, Siemens HJ, Sievers HH, Kaps M: Bigated transcranial Doppler for the detection of clinically silent circulating emboli in normal and patients with prosthetic cardiac valves. Stroke 1997;28:588–592.
15.
Babikian VL, Hyde Ch, Pochay V, Winter MR: Clinical correlates of high-intensity transient signals detected on transcranial doppler sonography in patients with cerebrovascular disease. Stroke 1994;25:1570–1573.
16.
Sitzer M, Siebler N, Steinmentz H: Silent emboli and their relation to clinical symptoms in extracranial carotid artery disease. Cerebrovasc Dis 1995;5:121–123.
17.
Ries S, Schminke U, Daffertshofer M, Schindlmayr C, Hennerici M: High intensity transient signals and carotid artery disease. Cerebrovasc Dis 1995;5:124–127.
18.
Siebler M, Kleinschmidt A, Sitzer M, Steinmetz H, Freund HJ: Cerebral microembolism in symptomatic and asymptomatic high-grade internal carotid stenosis. Neurology 1994;44:615–618.
19.
Markus HS, Thomson N, Brown MM: Asymptomatic cerebral embolic signals in symptomatic and asymptomatic carotid artery disease. Brain 1995;118:1005–1011.
20.
Kaps M, Hansen J, Weiher M, Tiffert K, Kayser I, Droste DW: Clinically silent microemboli in patients with artificial prosthetic aortic valves are predominantly gaseous and not solid. Stroke 1997;28:322–325.
21.
Russell D, Brucher R: Multifrequency doppler discriminates between gaseous and solid microemboli. Cerebrovasc Dis 1999;9:81.
22.
Devuyst G, Vesin JM, Thonet G, Despland PA, Bogousslavsky J: A new approach to discriminate gaseous from solid cerebral emboli by TCD. Cerebrovasc Dis 1999;9:81.
23.
Tegeler CH, Burke GL, Dalley GM, Stump DA: Carotid emboli predict poor outcome in stroke (abstract). Stroke. 1993;24:186.
24.
Babikian VL, Wijman CAC, Hyde C, Cantelmo NL, Winter MR, Baker E, Pochay V: Cerebral microembolism and early recurrent cerebral or retinal ischemic events. Stroke 1997;28:1314–1318.
25.
Valton L, Larrue V, Pavy Le Traon A, Géraud G: Cerebral microembolism in patients with stroke or transient ischaemic attack as a risk factor for early recurrence. J Neurol Neurosurg Psychiatry 1997;63:784–787.
26.
Molloy J, Markus HS: Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis. Stroke 1999;30:1440–1443.
27.
Siebler M, Nachtmann A, Sitzer M, Rose G, Kleinschmidt A, Rademacher J, Steinmetz H: Cerebral microembolism and the risk of ischemia in asymptomatic high-grade internal carotid artery stenosis. Stroke 1995;26:2184–2186.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.